Indication

Thoracic Tumors

1 clinical trial

3 products

3 drugs

Clinical trial

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol)

Status: Recruiting, Estimated PCD: 2026-11-04

Product

Drug

Drug

Drug

Product

Product